FDA approves 1st nonopioid drug to ease withdrawal symptoms - WKOW 27: Madison, WI Breaking News, Weather and Sports

FDA approves 1st nonopioid drug to ease withdrawal symptoms

Posted: Updated:
(US WorldMeds via AP). This undated photo provided by US WorldMeds shows Lucemyra. Federal regulators have approved the first nonopioid treatment to ease withdrawal symptoms from quitting opioids. (US WorldMeds via AP). This undated photo provided by US WorldMeds shows Lucemyra. Federal regulators have approved the first nonopioid treatment to ease withdrawal symptoms from quitting opioids.
  • NationalMore>>

  • Hall of fame to redo soccer star Brandi Chastain plaque

    Hall of fame to redo soccer star Brandi Chastain plaque

    Wednesday, May 23 2018 10:24 PM EDT2018-05-24 02:24:54 GMT
    (AP Photo/Mark J. Terrill, File). FILE - In this July 10, 1999, file photo, the United States' Brandi Chastain celebrates by taking off her jersey after kicking in the game-winning goal in a penalty shootout against China in the FIFA Women's World Cup ...(AP Photo/Mark J. Terrill, File). FILE - In this July 10, 1999, file photo, the United States' Brandi Chastain celebrates by taking off her jersey after kicking in the game-winning goal in a penalty shootout against China in the FIFA Women's World Cup ...
    Social media is finding little to like about the likeness on a plaque honoring retired soccer champion Brandi Chastain.More >>
    Social media is finding little to like about the likeness on a plaque honoring retired soccer champion Brandi Chastain.More >>
  • 93-year-old makes first hole-in-one in 65 years of golfing

    93-year-old makes first hole-in-one in 65 years of golfing

    Wednesday, May 23 2018 10:24 PM EDT2018-05-24 02:24:49 GMT
    (Chris Crook/Times Recorder via AP). In this April 2018 photo, Ben Bender capped his long golf career with a hole-in-one at Green Valley Golf Club in Zanesville, Ohio. Bender, who has hip bursitis, used his 5-wood to make a hole-in-one on the third hole.(Chris Crook/Times Recorder via AP). In this April 2018 photo, Ben Bender capped his long golf career with a hole-in-one at Green Valley Golf Club in Zanesville, Ohio. Bender, who has hip bursitis, used his 5-wood to make a hole-in-one on the third hole.
    A 93-year-old Ohio man made his first hole-in-one in 65 years of golfing and then walked off the course for good a few holes later.More >>
    A 93-year-old Ohio man made his first hole-in-one in 65 years of golfing and then walked off the course for good a few holes later.More >>
  • Truck dumps 40,000 pounds of chicken feathers on highway

    Truck dumps 40,000 pounds of chicken feathers on highway

    Wednesday, May 23 2018 10:24 PM EDT2018-05-24 02:24:45 GMT
    A semi-truck made in Washington state dumped about 40,000 pounds (more than 18,000 kilograms) of chicken feathers across Interstate 5.More >>
    A semi-truck made in Washington state dumped about 40,000 pounds (more than 18,000 kilograms) of chicken feathers across Interstate 5.More >>

By LINDA A. JOHNSON
AP Medical Writer

TRENTON, N.J. (AP) - Federal regulators on Wednesday approved the first nonopioid treatment to ease withdrawal from quitting addictive opioids.

The U.S. Food and Drug Administration expedited approval of Lucemyra to help combat the U.S. opioid epidemic. Two-thirds of drug overdose deaths in 2016 involved opioids, mostly fentanyl, heroin and prescription painkillers.

The pill was approved to treat adults for up to two weeks for common withdrawal symptoms like vomiting, diarrhea, muscle pain and agitation. It is not an addiction medicine but can be part of a longer-term treatment plan, according to the FDA.

People going through detox are usually given a safer opioid medicine like methadone, which eases the cravings without an intense high.

"The fear of experiencing withdrawal symptoms often prevents those suffering from opioid addiction from seeking help," FDA Commissioner Dr. Scott Gottlieb said in a statement.

In two studies of 866 adults, those given Lucemyra reported less severe withdrawal symptoms when they abruptly stopped taking opioids, compared to those who were given dummy pills.

Side effects included low blood pressure, dizziness, sleepiness, slow heart rate and, in a few people, fainting.

The FDA is requiring drugmaker US WorldMeds of Louisville, Kentucky, to conduct more studies in teens and newborns of opioid-addicted mothers and for possible longer-term use in people tapering off opioids.

Privately held US WorldMeds said it had not yet set a price for Lucemyra.

___

Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Powered by Frankly